MedTrace Logo

The Role of Vitamin D in Neuroinflammatory on Drug Resistant Epilepsy

NCT06053281 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-02-14

No results posted yet for this study

Summary

The incident of epilepsy still very high in Indonesia, thus many patients become drug resistant epilepsy. As vitamin D has some anticonvulsant effect, the investigators want to study if an additional dose of vitamin D can help with the therapy responses.

Conditions

  • Drug Resistant Epilepsy

Interventions

DRUG

Cholecalciferol

Daily Cholecalciferol 1000 IU in 24 weeks

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • DINA KEUMALA SARI

    lead OTHER

Principal Investigators

  • Dina K. Sari, SpGK(K), Prof.Dr.dr. · Universitas Sumatera Utara

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-19
Primary Completion
2024-12-31
Completion
2025-07-01

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06053281 on ClinicalTrials.gov